A general method for exploiting QSAR models in lead optimization

Journal of Medicinal Chemistry

Volumn 48, Issue 5, 2005, Pages 1638-1648

  Lewis, Richard A ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H3 RECEPTOR ANTAGONIST;

ARTICLE; AUTOMATION; COMPUTER AIDED DESIGN; DRUG DESIGN; DRUG STRUCTURE; METHODOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ALGORITHMS; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; DRUG DESIGN; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 14944350238     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049228d     Document Type: Article

References (39)

1. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25.
2. King, R.; Muggleton, S.; Lewis, R. A.; Sternberg, M. J. E. Drug design by machine learning: The use of inductive logic programming to model the structure-activity relationships of trimethoprim analogues binding to dihydrofolate reductase. Proc. Nat. Acad. Sci. U.S.A. 1992, 89, 11322-11326.
3. Marchand-Geneste, N.; Watson, K. A.; Alsberg, B. K.; King, R. D. New Approach to Pharmacophore Mapping and QSAR Analysis Using Inductive Logic Programming. Application to Thermolysin Inhibitors and Glycogen Phosphorylase b Inhibitors. J. Med. Chem. 2002, 45, 399-409.
4. Abraham, M. H. Scales of solute hydrogen-bonding: Their construction and application to physicochemical and biochemical processes. Chem. Soc. Rev. 1993, 22, 73-83.
5. Tong, W.; Lowis, D. R.; Perkins, R.; Chen, Y.; Welsh, W. J.; Goddette, D. W.; Heritage, T. W.; Sheehan, D. M. Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J. Chem. Inf. Comput. Sci. 1998, 38, 669-677.
6. Wall, L.; Christiansen, T.; Orwant, J. Programming Perl; O' Reilly: Sebastopol; 2002.
7. Cerius2, available from Accelrys Inc.
8. THINK, available from Treweren Consultants; www.treweren. com.
9. Lewis, R. A.; Mason, J. S.; McLay, I. M. Similarity Measures for Rational Set Selection and Analysis of Combinatorial Libraries: The Diverse Property-Derived (DPD) Approach. J. Chem. Inf. Comput. Sci. 1997, 37, 599-614.
10. Hann, M.; Hudson, B.; Lewell, X.; Lifely, R.; Ramsden, N. Strategic Pooling of Compounds for High-Throughput Screening. J. Chem. Inf. Comput. Sci. 1999, 39, 897-902.
11. Rishton, G. M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discovery Today 2002, 8, 86-96.
12. Higgs, R. E.; Bemis, K. G.; Watson, I. A.; Wikel, J. H. Experimental Designs for Selecting Molecules from Large Chemical Databases. J. Chem. Inf. Comput. Sci. 1997, 37, 861-870.
13. Vinkers, H. M.; de Jonge, M. R.; Daeyaert, F. F. D.; Heeres, J.; Koymans, L. M. H.; van Lenthe, J. H.; Lewi, P. J.; Timmerman, H.; Van Aken, K.; Janssen, P. A. J. SYNOPSIS: SYNthesize and OPtimize system in silico. J. Med. Chem. 2003, 46, 2765-2773.
14. Takaoka, Y.; Endo, Y.; Yamanobe, S.; Kakinuma, H.; Okubo, T.; Shimazaki, Y.; Ota, T.; Sumiya, S.; Yoshikawa, K. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition. J. Chem. Inf. Comput. Sci. 2003, 43, 1269-1275.
15. Johnson, M. A.; Maggiore, G. M. Concepts and Applications of Molecular Similarity; J. Wiley: New York, 1990.
16. Wermuth, C. G. Molecular variations based on isosteric replacements. In Practice of Medicinal Chemistry; Wermuth, C. G., Ed.; Academic Press: 1996; pp 202-237.
17. Scozzafava, A.; Menabuoni, L.; Mincione, F.; Briganti, F.; Mincione, G.; Supuran, C. T. Carbonic Anhydrase Inhibitors: Perfluoroalkyl/Aryl-Substituted Derivatives of Aromatic/Heterocyclic Sulfonamides as Topical Intraocular Pressure-Lowering Agents with Prolonged Duration of Action. J. Med. Chem. 2000, 43, 4542-4551.
18. Mattioni, B. E.; Jurs, P. C. Development of Quantitative Structure-Activity Relationship and Classification Models for a Set of Carbonic Anhydrase Inhibitors. J. Chem. Inf. Comput. Sci. 2002, 42, 94-102.
19. Corina, available from Molecular Networks GmbH. www. mol-net.de
20. Todeschini R.; Consonni V. Handbook of Molecular Descriptors. 2000, Wiley-VCH: Weinheim.
21. Available from Daylight Chemical Information Systems, Inc. www.daylight.com
22. Lewis, R. A.; Roe, D. C.; Huang, C.; Ferrin, T. E.; Langridge, R.; Kuntz, I. D. Automated Site-directed Drug Design using Molecular Lattices. J. Mol. Graphics 1992, 10, 66-78.
23. Miko, T.; Ligneau, X.; Pertz, H. H.; Ganellin, C. R.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W.; Stark, H. Novel Nonimidazole Histamine H3 Receptor Antagonists: 1-(4-(Phenoxymethyl)-benzyl)piperidines and Related Compounds. J. Med. Chem. 2003, 46, 1523-1530.
24. Venkatasubramanian, V.; Chan, K.; Caruthers, J. M. Evolutionary design of molecules with desired properties using the genetic algorithm. J. Chem. Inf. Comput. Sci. 1995, 35, 188-195.
25. Sheridan, R. P.; Kearsley, S. K. Using a Genetic Algorithm To Suggest Combinatorial Libraries. J. Chem. Inf. Comput. Sci. 1995, 35, 310-320.
26. Weber, L.; Almstetter, M. Diversity in very large libraries. In Molecular Diversity in Drug Design; Dean, P. M., Lewis R. A., Eds.; Kluwer: 1999; pp 93-114.
27. Skvortsova, M. I.; Baskin, I. I.; Slovokhotova, O. L.; Palyulin, V. A.; Zefirov, N. S. Inverse problem in QSAR/QSPR studies for the case of topological indices characterizing molecular shape (Kier indices). J. Chem. Inf. Comput. Sci. 1993, 33, 3, 630-63.
28. Kier, L. B.; Hall, L. H. The generation of molecular structures from a graph-based QSAR equation. Quant. Struct.-Act. Relat. 1993, 12, 383-388.
29. Hall, L. H.; Fisk, J. B. Computer generation of vertex degree sets for chemical graphs from a number of vertices and rings. J. Chem. Inf. Comput. Sci. 1904, 34, 5, 1184-1189.
30. Kvasnicka, V.; Pospichal, J. Simulated annealing construction of molecular graphs with required properties. J. Chem. Inf. Comput. Sci. 1996, 36, 6, 516-526.
31. Faulon, J.-L.; Visco, D. P., Jr.; Pophale, R. S. The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 2003, 43, 707-720.
32. Faulon, J.-L.; Churchwell, C. J.; Visco, D. P., Jr. The signature molecular descriptor. 2. Enumerating molecules from their extended valences sequences. J. Chem. Inf. Comput. Sci. 2003, 43, 721-734.
33. Weininger, D. Method and Apparatus for Designing Molecules with Desired Properties by Evolving Successive Populations. U.S. Patent No. 5,434,796, 1995.
34. Walker, J. D.; Carlsen, L.; Jaworska, J. Improving opportunities for regulatory acceptance of QSARs: The importance of model domain, uncertainty, validity and predictability. Quant. Struct.-Act. Relat. 2003, 22, 346-350.
35. Bishop, C. M. Novelty detection and neural network validation. IEEE. Proc.-Vis. Image Signal Process 1994, 141, 217-222.
36. McKenna, J. M.; Halley, F.; Souness, J. E.; McLay, I. M.; Pickett, S. D.; Collis, A. J.; Page, K.; Ahmed, I. An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J. Med. Chem. 2002, 45, 2173-2184.
37. Wright, T.; Gillet, V. J.; Green, D. V. S.; Pickett, S. D. Optimizing the size and configuration of combinatorial libraries. J. Chem. Inf. Comput. Sci. 2003, 43, 381-390.
38. EA-inventor, available from www.optive.com
39. Brown, N.; McKay, B.; Gilardoni, F.; Gasteiger, J. A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J. Chem. Inf. Comput. Sci. 2004, 44, 1079-1087.